Fluicell
@fluicell.com did:plc:t4ksn2qqqemwwnbyppdpm6ld
Transforming how we treat diseases with high precsision tissue solutions. We are developing advanced human cardiac drug screening models and tissue-based type 1 diabetes therapeutics. 👉 https://www.fluicell.com/
Bluesky’a katılma tarihi:
- Takipçi
- 116
- Takip edilen
- 272
- Post
- 50
- Sıralamaya girdiği gün
- 0
Özet
Fluicell (@fluicell.com), 27 Eylül 2023 tarihinde katılan bir Bluesky kullanıcısı. 116 takipçisi var, 272 hesabı takip ediyor ve 50 post paylaştı.
Sıralama geçmişi
Bu hesabın postlarının Debya günlük listesine girdiği en iyi günler.
Bu hesap henüz günlük sıralamaya girmedi.
Son beğendiği postlar
Bluesky ağındaki herkese açık beğeniler.
In recognition of Breast Cancer Awareness Month, Knight School will host presentations on recent discoveries and innovations in breast cancer research, treatment, and patient care. 💞 🗓️ October 20 ⏰ 6 PM 📍Knight Cancer Research Building
Postu gösterIn 1922, insulin co-discoverer Frederick Banting refused to profit from the discovery and offered it to the world as a global public good. Today, many people with diabetes still don't have access to affordable and quality treatment and care.
Postu göster🧪
Postu gösterPeople Behind the Science podcast interviewed Dr. Luiz Bertassoni, director of @ohsuknight.bsky.social's Precision Biofabrication Hub. On this episode, Dr. Bertassoni discusses what got him hooked on science, life outside the lab, and advice for future scientists. Listen 🎧⤵️
Postu gösterCellular architecture and neighborhood-informed virtual spatial tumor profiling from histopathology @cellcellpress.bsky.social @stanforduniversity.bsky.social www.cell.com/cell/fulltex...
Postu göster
Blokladığı hesaplar
Bluesky’da bloklar herkese açık kayıtlardır.
Bu hesap kimseyi bloklamıyor.